LipiFlow® is the only FDA approved treatment for Meibomian Gland Dysfunction (MGD). MGD affects 86% of patients with dry eye symptoms – making it the most common form of dry eye.
Lifestyle Eye Center now offers dry eye treatment LipiFlow
There are nearly 30 million people in the United States and over 300 million worldwide who have been diagnosed with dry eye. Most have learned to live with eye discomfort and have become dependent on drops and treatment methods that only offer temporary relief.

MGD is a chronic and progressive disease, and should be detected and treated early to avoid permanent damage and life-long symptoms.

Understanding MGD

Many commonly attribute their eye discomfort to dry eye when the root cause of the burning, scratching, and redness is most likely MGD.

MGD occurs when there is compromise to the function and/or structure of the meibomian glands in the eyelids that produce the protective oily layer of the tear film.

This oil helps protect the ocular surface from disease and prevents the watery part of the tears from evaporating when your eyes are open.

Without these oils, our eyes become more susceptible to negative effects that dry climates, air conditioning, computer use, reading and other daily activities can have on the long-term health of our eyes.

MGD Identification

To assess meibomian gland health and to identify MGD, both meibomian gland function and structure are evaluated.

Gland Function
Function is evaluated by assessing how the glands respond to gentle force, approximating that of a deliberate blink. The blink health, which is crucial to maintaining gland function, is assessed by determining the completeness of each blink.

Gland Structure
Structural compromise, which is otherwise invisible, can be identified and captured with high definition gland imaging. Structural compromise is most likely irreversible, and if left untreated will continue to progress.

treating the most common form of dry eye

Treating MGD with LipiFlow

Lifestyle eye center will treat your dry eye with Lipiflow LipiFlow is the only FDA approved device for removing gland blockages and restoring gland function.

LipiFlow treatment utilizes a patented algorithm of heat applied to the inner eyelids and massage to remove the obstructions in your meibomian glands.

The procedure takes approximately 12 minutes, and patients feel heat and gentle massage on the eyelids as the LipiFlow works to restore oil flow from the meibomian glands.

Dr. Tara Evanger is our dry eye specialist. She is certified through Dry Eye University, and can answer any questions that you or your doctor might have.

The LipiFlow Procedure

From TearScience on Vimeo

Find out if LipiFlow is Right for you – Talk to your doctor today

Contact our office if you have any questions!